Predicted protein targets (top 13)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MAPT | P10636 | 2/20 | 0.61 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.61 |
| ▸ | LMNA | P02545 | 4/20 | 0.59 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.56 |
| ▸ | DUSP3 | P51452 | 1/20 | 0.56 |
| ▸ | MEN1 | O00255 | 1/20 | 0.56 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.56 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.53 |
| ▸ | PRKCA | P17252 | 3/20 | 0.53 |
| ▸ | PRKCE | Q02156 | 1/20 | 0.53 |
| ▸ | PRKCQ | Q04759 | 1/20 | 0.53 |
| ▸ | PRKCD | Q05655 | 1/20 | 0.53 |
| ▸ | DGKA | P23743 | 2/20 | 0.48 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL10557312 | 1.00 | MAPT (0.61) | MAPTMAPK1LMNAKDM4EDUSP3 | |
| SCHEMBL8047747 | 0.91 | MAPT (0.59) | MAPTMAPK1LMNAKDM4EDUSP3 | |
| SCHEMBL28478639 | 0.91 | MAPT (0.59) | MAPTMAPK1LMNAKDM4EDUSP3 | |
| SCHEMBL28703557 | 0.91 | DGKA (0.62) | MAPTMAPK1LMNAALDH1A1PRKCA | |
| SCHEMBL28565212 | 0.90 | MAPT (0.57) | MAPTMAPK1LMNAKDM4EDUSP3 | |
| SCHEMBL28787987 | 0.90 | MAPT (0.57) | MAPTMAPK1LMNAKDM4EDUSP3 | |
| SCHEMBL28722210 | 0.90 | MAPT (0.57) | MAPTMAPK1LMNAKDM4EDUSP3 | |
| SCHEMBL29242233 | 0.90 | MAPT (0.57) | MAPTMAPK1LMNAKDM4EDUSP3 | |
| SCHEMBL2274579 | 0.90 | MAPT (0.57) | MAPTMAPK1LMNAKDM4EDUSP3 | |
| SCHEMBL10880392 | 0.89 | LMNA (0.63) | MAPTMAPK1LMNAKDM4EDUSP3 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 15 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20210230363-A1 | DERIVATIVES OF 1,3-PROPANEDIOL | VANTAGE SPECIALTY CHEMICALS INC (US) | 2021-07-29 | — | — | US | claimed |
| CN-113373687-B | Treating agent for artificial silk ear and artificial silk ear using the same | 三吉油脂株式会社 | 2025-02-18 | — | — | CN | disclosed |
| CN-113373687-A | Agent for treating artificial silk ear barrel and artificial silk ear barrel using same | 三吉油脂株式会社 | 2021-09-10 | — | — | CN | disclosed |
| US-20210230363-A1 | DERIVATIVES OF 1,3-PROPANEDIOL | VANTAGE SPECIALTY CHEMICALS INC (US) | 2021-07-29 | — | — | US | disclosed |
| CN-106413677-B | It is anti-aging to use skin preparations for extenal use | 株式会社林原 | 2019-09-24 | — | — | CN | disclosed |
| US-20170298178-A1 | DERIVATIVES OF 1,3-PROPANEDIOL | VANTAGE SPECIALTY CHEMICALS, INC. (US) | 2017-10-19 | — | — | US | disclosed |
| EP-3215552-A1 | DERIVATIVES OF 1,3-PROPANEDIOL | Vantage Specialty Chemicals, Inc. (US) | 2017-09-13 | — | — | EP | disclosed |
| CN-106413677-A | Anti-aging external skin preparation | 株式会社林原 | 2017-02-15 | — | — | CN | disclosed |
| WO-2016040956-A1 | DERIVATIVES OF 1,3-PROPANEDIOL | VANTAGE SPECIALTY CHEMICALS, INC. (US) | 2016-03-17 | — | — | WO | disclosed |
| CN-101006052-B | Pyrrole derivatives as pharmaceutical agents | EXELIXIS INC | 2013-11-06 | — | — | CN | disclosed |
| CN-101006052-A | Pyrrole derivatives as pharmaceutical agents | EXELIXIS INC (US) | 2007-07-25 | — | — | CN | disclosed |
| CN-1143690-C | Silicate-containing powders providing controlled sustained gas release | ��������ͨ���о�Ժ | 2004-03-31 | — | — | CN | disclosed |
| CN-1313770-A | Silicate-containing powders providing controlled, sustained gas release | SOUTHWEST RES INST (US) | 2001-09-19 | — | — | CN | disclosed |
| WO-1994018830-A1 | ORGANIC PEROXIDE COMPOSITIONS AND PROCESS THEREFOR | AZTEC PEROXIDES, INC. (US) | 1994-09-01 | — | — | WO | disclosed |
| US-5276202-A | Stabilization of peroxides with phlegmatization agent with polyesters for plasticizing | PHILLIPS PETROLEUM COMPANY (US) | 1994-01-04 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20210230363-A1 | DERIVATIVES OF 1,3-PROPANEDIOL | BBOX1, PGD, DDT | MAPT 1201/4885MAPK1 3527/4885LMNA 3575/4885 |
| US-20170298178-A1 | DERIVATIVES OF 1,3-PROPANEDIOL | BBOX1, PGD, DDT | MAPT 1201/4885MAPK1 3527/4885LMNA 3575/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.